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A microscale optical implant for continuous in vivo monitoring
of intraocular pressure
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Intraocular pressure (IOP) is a key clinical parameter in glaucoma management. However, despite the potential utility of daily
measurements of IOP in the context of disease management, the necessary tools are currently lacking, and IOP is typically
measured only a few times a year. Here we report on a microscale implantable sensor that could provide convenient, accurate, on-
demand IOP monitoring in the home environment. When excited by broadband near-infrared (NIR) light from a tungsten bulb, the
sensor’s optical cavity reﬂects a pressure-dependent resonance signature that can be converted to IOP. NIR light is minimally
absorbed by tissue and is not perceived visually. The sensor’s nanodot-enhanced cavity allows for a 3–5 cm readout distance with
an average accuracy of 0.29 mm Hg over the range of 0–40 mm Hg. Sensors were mounted onto intraocular lenses or silicone
haptics and secured inside the anterior chamber in New Zealand white rabbits. Implanted sensors provided continuous in vivo
tracking of short-term transient IOP elevations and provided continuous measurements of IOP for up to 4.5 months.
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INTRODUCTION
Glaucoma is the leading cause of irreversible blindness1,2, with a
signiﬁcant portion of patients exhibiting progressive vision loss
despite treatment3–6. Current therapies aim to lower elevated
intraocular pressure (IOP), which is the only known modiﬁable risk
factor and thus the key parameter for clinical monitoring7–10.
Despite its central role in glaucoma management, IOP is measured
only a few times a year using specialized tonometers in the clinic.
These infrequent ‘snapshot’ views of IOP are problematic because
an individual’s IOP can ﬂuctuate on a daily, weekly, or seasonal
basis11–16. IOP can be inﬂuenced by activity, diet, and other factors
that are not completely understood17–21. If the daily (or more
frequent) IOP pattern of a glaucoma patient is available, the
physician can predict disease progression and personalize therapy
based on detailed knowledge of individualized trends in IOP22. This
is similar to the approach used to treat other chronic progressive
diseases such as hypertension and diabetes, in which home
monitoring of blood pressure and blood sugar is integral to disease
management.
In addition, pathophysiological studies and drug-discovery
research demand accurate, frequent, and preferably automated
assessments of IOP in humans and testing animals23,24. Over
recent decades, animal models have signiﬁcantly contributed to
the understanding of the cellular and molecular bases of
glaucoma25. However, the relationship between IOP and other
factors, such as obesity, genetic contributions26,27, retinal ganglion
cell death28, age, and ocular blood circulation29, are not fully
understood yet due to the limited accuracy and usability of
conventional tonometry. All tonometry approaches available in
practice, such as rebounding tonometry, pneumotonometry,
dynamic contour tonometry, and Goldmann applanation tono-
metry, perform indirect measurements of IOP. The accuracy of
these approaches is adversely inﬂuenced by variations in
individual corneal biomechanics30 and measurement complexity,
rendering them unsuitable for use in large-scale animal studies.
Recently developed contact-lens-based IOP sensors also provide
indirect IOP measurements. They track changes in the corneal
scleral angle as a surrogate measure and provide relative IOP
trends in mV rather than mm Hg31–40. Such measurements can
only be obtained for up to 24 h because of side complications that
accompany long-term use41–43.
To overcome the aforementioned limitations, implants based on
radio-frequency (RF) technologies have been used to monitor
endovascular pressure44, intracranial pressure (ICP)45,46, and
IOP47–58. The typical size of these implants ranges from a millimeter
to a few centimetres. The implant’s inductive coils occupy most of
this space; a larger coil is required to achieve a longer readout
distance and better accuracy52,59. For ophthalmic implants, sensor
miniaturization is important because the space available for an
ocular implant is very small, especially in research animals (e.g.,
mice) with corneal diameters of approximately 3 mm60,61. Some of
the RF-based IOP sensors were miniaturized down to the
millimeter scale, but their practical use has been limited by short
readout distances or the need for sophisticated measurement
equipment (for example, spectrum, vector-network analyser) for
readout62,63. As a result, in vivo measurements have thus far been
obtained only with large RF implants that measure 0.5 to 1 cm in
diameter51,64,65. Such large implants have damaged surrounding
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tissues and led to medical complications66,67. Previously investi-
gated optical sensing approaches include a ﬁber-tip-based
interferometry for hydrostatic pressure sensing68–74, a visual-
identiﬁcation-based method applied to pressure-sensitive
microﬂuidic or micromechanical structures75,76, and laser-excited
ﬂuorescence measurements for ICP and IOP monitoring77,78. These
approaches are promising, and with more improvements in terms
of miniaturization and readout techniques, they may become
practical approaches for IOP monitoring.
Here, we report an IOP-monitoring system that consists of a
microscale implantable optical sensor (900 μm in diameter) and a
remote optical readout detector for use in clinics, laboratories, and
potentially home environments. The demonstrated advantages of
our approach include: (1) microscale sizes that allow minimally
invasive and safe sensor implantation in the eye using well-
established intraocular lens (IOL)79 or silicone-haptics procedures;
(2) a practical readout distance of 3 to 5 cm, which can be
extended beyond 10 cm; (3) the use of non-invasive near-infrared
(NIR) light from a tungsten bulb that is not perceived by the
patient; and (4) excellent pressure-measurement accuracy (mean
average: 0.29 mm Hg; maximum deviation: o1 mm Hg) over the
clinically relevant IOP range of 0–40 mm Hg at a continuous
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Figure 1 A microscale nanodot-enhanced intraocular pressure (IOP) sensor and operating principles. (a) A three-dimensional (3D) illustration
of the top structure with a nanodot-embedded deformable SiN membrane and the bottom structure with a Si reﬂective surface in the center
and a cylindrical hollow cavity, before assembly. (b) A cross-sectional schematic view of an assembled sensor and a zoomed-in image of the
nanodot array in the SiN membrane (inset). (c) A microscope image taken perpendicular to the device surface showing the square nanodot
array in the middle of the sensor (scale bar: 500 μm). (d) Scanning electron microscopy (SEM) image of the gold nanodot array on a SiN
membrane: the diameter of each dot is 600 nm (scale bar: 2 μm). (e) A photograph of a completed device with a diameter of 900 μm (inset: a
zoomed-in image of the sensor taken at an angle at which the rectangular nanodot array assumes a green-blue color). (f) A nanodot-
enhanced IOP sensor located in the anterior chamber and interrogated using NIR light. (g) A schematic illustrating the shift in the sensor-
reﬂected resonance as a function of the gap distance within the sensor’s optical cavity, which in turn is related to IOP.
A microscale intraocular pressure-sensing implant
JO Lee et al
2
Microsystems & Nanoengineering doi:10.1038/micronano.2017.57
measurement rate of 10 Hz. Using our IOP-sensing implant and
readout system, we have successfully tracked artiﬁcially induced
short-term transient IOP elevations in anesthetized rabbits for a
period of 1 h. We also tracked long-term changes in IOP in awake
rabbits over the course of 4.5 months. Our sensor measurements
were veriﬁed using readouts concurrently obtained using the
Tonovet (Icare, Vanda, Finland), and comparison between the
measurement sets revealed good consistency.
MATERIALS AND METHODS
A microscale nanodot-enhanced IOP sensor and principles of
operation
The implantable IOP sensor is a hermetically sealed hollow disk
that serves as a pressure-sensitive optical resonant cavity. It
consists of a top half that is in the form of a micromachined silicon
ring with a deformable silicon-nitride (SiN) membrane and a
bottom half that contains a solid reﬂective Si surface that serves as
a mirror (Figures 1a and b).
The two halves are assembled together using medical grade
epoxy, resulting in a 7-μm gap between the SiN membrane and
the Si mirror that forms the optical cavity. The optical resonance
of the cavity is further enhanced by the placement of a gold
nanodot array fabricated onto the deformable SiN membrane
(Figures 1b–d). The gold nanodot array optimizes the reﬂectivity of
the top SiN membrane to match the reﬂectivity of the bottom
silicon surface and maximizes the amplitude of the optical
resonance. The nanodot array dimensions for optimal membrane
reﬂectivity were identiﬁed using parametric ﬁnite-difference-time-
domain (FDTD) simulations and experimental measurements
(Supplementary Figure S1). Based on this analysis, a
200 × 200 μm2 array with a dot diameter of 600 nm and dot-to-
dot pitch of 1000 nm (Figures 1c and d) was used to double the
amplitude of the cavity resonance. The ﬁnal sensor dimensions
after assembly are 900 μm in diameter and 600 μm in height, thus
the area of the assembled sensor including the surrounding Si
frame is 0.635 mm2 and the volume is 0.381 mm3 (Figure 1e).
Moreover, the area of the core optomechanical cavity is 0.283 mm2
(600 μm in diameter) occupying only 44% of the entire sensor area
and suggesting further miniaturization. This compact size is an
order of magnitude smaller than the state-of-the-art research
devices46,62,63 and three orders of magnitude smaller than
commercially available sensors65.
For IOP monitoring, the sensor is implanted into the eye where
its deformable SiN membrane is exposed to the IOP and
interrogated using the broadband invisible NIR regime (800–
1100 nm) of a tungsten light bulb (Figure 1f) (see in vivo testing
below for details on the sensor implantation). At a given IOP, the
sensor has an associated gap size and reﬂects a characteristic
resonance that will have a spectral signature or a spectrum
consisting of reﬂectance extrema, that is, peaks and dips, at speciﬁc
wavelengths (Figure 1g, top). When the IOP increases, the ﬂexible
SiN membrane is deﬂected inwards and causes the gap to decrease,
and consequently this results in a new resonance spectral signature
consisting of reﬂectance dips that are shifted to shorter wave-
lengths (Figure 1g, bottom). When the IOP decreases, the SiN
membrane deﬂects outwards and causes the gap to increase, and
the new resonance spectrum will consist of reﬂectance dips that are
shifted to longer wavelengths. The location of these resonance
peaks and dips can be identiﬁed using a commercially available
mini-spectrometer and used to determine the gap separation and
therefore the ambient pressure, that is, the IOP.
Design of the nanodot-enhanced IOP sensor
We chose the near infrared (NIR) wavelength range of 800–
1100 nm as a broadband light source to take advantage of the fact
that NIR light is minimally absorbed in the cornea and the
aqueous humor and is also invisible to the human eye.
SiN was selected as the material for the deformable membrane
due to its high optical transparency, large refractive index,
extremely low water permeability, and robust mechanical
resilience. The relatively high refractive index of 1.98 for SiN
allows the implementation of a sensor cavity with a strong optical
resonance in saline or aqueous humor because the resonance
amplitude of an optical cavity is heavily dependent on the
reﬂectivity of its surfaces. If the reﬂectivity is too high or too low,
the resonance may become very sharp or ﬂat, which signiﬁcantly
lowers the SNR 80–82.
The thickness of the SiN membrane was optimized to maximize
the amplitude of the sensor resonance. In preliminary studies, we
observed that the detected sensor-resonance spectrum was the
result of two separate resonances: one from the thickness of the
silicon-nitride membrane, and the other from the cavity gap
between the nitride membrane and the bottom silicon surface.
The resonance from the silicon nitride membrane deﬁnes the
outer low-frequency envelope while that of the cavity forms the
inner higher frequency component (Supplementary Figure S2).
Hence, using FDTD simulation, we determined that the optimal
thickness of the silicon-nitride membrane was 0.3 μm, which
allowed the maximum of the outer low-frequency envelope to be
centered in the 800–1100 nm range.
The optimal diameter for the 0.3 μm-thick SiN membrane was
determined using a series of ﬁnite-element-method (FEM)
simulations and a high-order analytical model for a thin
diaphragm (Supplementary Figure S3)83,84. For the pressure range
between 0 and 40 mm Hg, SiN membranes with diameters
between 200 and 1000 μm were all found to exhibit linear
deformation as a response to hydrostatic pressure changes. For
the present proof-of-concept study, 600 μm was conservatively
chosen as the SiN-membrane diameter to facilitate the fabrication
and assembly requirements.
The dimensions of a gold-nanodot array for optimal membrane
reﬂectivity were identiﬁed using a series of ﬁnite-difference-time-
domain (FDTD) simulation and experimental measurements84. The
use of an optimized 200× 200-μm2 array with a dot diameter of
600 nm and dot-to-dot pitch of 1000 nm doubles the amplitude of
the cavity resonance. And, the cavity gap was set at 7 μm to
obtain approximately three peaks and three valleys in the
reﬂection spectra. The presence of multiple peaks and valleys in
a single spectrum improves the accuracy of the IOP determination.
IOP-sensor fabrication
The top half of the sensor with a SiN membrane was created by
growing 2 μm-thick thermal silicon dioxide (SiO2) and a 300 nm-
thick silicon-nitride (SiN) layer using a low pressure chemical
vapor-deposition technique in sequence on a double-side-
polished wafer (diameter: 4 inches; thickness: 300 μm). The SiN
and SiO2 layers on one side of the wafer were completely
removed using reactive ion etching, followed by buffered
hydroﬂuoric (BHF) acid.
The hollow circular opening in the top structures was created
by ﬁrst depositing a 300-nm-thick Al2O3 layer in an e-beam
evaporator (Mark 50 System, CHA Industries, Inc., Fremont, CA,
USA) onto the cleaned side of the wafer. Photolithography
(photoresist: AZ 9245, AZ Electronic Materials, USA Corp.,
Branchburg, NJ, USA) was then used to deﬁne solid disks in the
Al2O3 layer as masks, and Bosch deep reactive ion etching
(Plasmalab System 100 RIE/ICP, Oxford Instruments, Abingdon, UK)
was performed through the wafer at an etch rate of 1–2 μm per
min, stopping at the SiO2 layer at the bottom surface of the wafer.
The gold-nanodot arrays were placed on the SiN membrane by
ﬁrst soaking the top structure wafer in BHF to remove the SiO2
layer, and electron-beam lithography (Raith EBPG 5000+ Electron
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Beam Writer, Raith Nanofabrication, Dortmund, Germany) was
then performed to pattern the gold nanodots on the suspended
SiN membrane. To separate out each individual top structure from
the processed wafer, another run of the reactive ion-etching (RIE)
process was used as a dicing step.
The bottom structure of the sensor, which consists of a
reﬂective Si surface and a hollow cylindrical cavity, was fabricated
in another Si wafer. A carefully controlled Bosch process was used
to create 7 μm-deep cylindrical trenches with a smooth bottom
surface (AFM-measured peak-to-peak roughness: 1.3 nm) to serve
as the mirror in the sensor cavity. Finally, the top and bottom
structures were aligned under a microscope and bonded together
using a medical grade epoxy. All sensors were pre-characterized in
a pressurized chamber after fabrication and devices with high SNR
values (415 dB) were selected for implantation.
RESULTS
Sensor characterization in a controlled pressure chamber
The accuracy, range, and linearity of the fabricated nanodot-
enhanced sensors were tested in a controlled pressure chamber
ﬁlled with saline (Figure 2a). We varied the pressure inside the
chamber between 0 to 100 mm Hg at steps of 0.05 mm Hg using
an integrated water column and a programmable syringe pump
(NE 1000, ABC Scientiﬁc, CA, USA). We monitored the pressure
using an electronic pressure sensor (1210 Pressure Sensor, TE
Connectivity Ltd., Schaffhausen, Switzerland) with an accuracy of
± 0.1 mm Hg. A custom-built table-top detection system
(Figure 2a; See section “Custom-Built Optical Detector” in
Supplementary Information) was used to excite the sensor’s
optical cavity with broadband NIR light (800–1100 nm) through an
optically transparent window located in the lid of the chamber.
The reﬂected optical resonance spectra from the sensor were then
collected using a commercially available mini-spectrometer
(MAYA 2000 Pro, Ocean Optics, Dunedin, FL, USA) that was
connected to the detection system.
As expected, the reﬂectance dips in the spectra of the sensor
showed a systematic shift to shorter wavelengths as the gap of
the sensor cavity decreased with increasing hydrostatic pressure
(Figure 2b). The experimentally measured spectral shifts
(Figure 2b) matched well with the theoretically predicted spectra
(Figure 2c). The analytical prediction was ﬁrst performed by an
optomechanical model (OMM) that consisted of physical and
material parameters, enabling the calculation of ambient pressure
for any given spectrum measurement (See Supplementary S4 and
S5). The pressure calculation relied on the fact that each pressure
(or each cavity gap) produced multiple resonance peaks with
unique locations and adjacent spacing that allowed us to achieve
one-to-one mapping between the measured spectrum and its
corresponding IOP85. In the pressure range from 0 to 40 mm Hg,
the nanodot-enhanced sensor showed highly linear responses,
and the deviations from the electronic pressure-gauge reading
remained below 1 mm Hg with root mean square error (RMSE) of
0.29 mm Hg (Figure 2d).
Sensor characterization in ex vivo rabbit eyes
The sensors that were evaluated in the controlled pressure
chamber were next characterized in ex vivo rabbit eyes. The
sensors were inserted through a clear corneal incision and placed
directly onto the iris with the SiN-membrane side facing up.
(Figures 3a and b).
The IOP was then systematically increased via saline infusion at
steps of 1 mm Hg. The resulting IOP was monitored using a 21-
gauge needle that was directly inserted into the anterior chamber
and connected to the same digital pressure gauge that has been
used for the characterizations in the controlled pressure chamber.
In parallel, the resonance spectral signatures of the sensor were
collected using the previously described detector system.
Figures 3c and d show the spectral measurements made for the
same sensor in the controlled pressure chamber and in an ex vivo
rabbit eye. The extrema locations from both the test chamber
characterizations (Figure 3c) and the ex vivo eye characterizations
(Figure 3d) for the same sensor are very consistent with one
another. The differences between the readouts from the same
nanodot-enhanced sensor implanted inside an ex vivo eye and the
concurrently obtained readouts from the digital pressure gauge
connected to the same ex vivo eye were less than 1.3 mm Hg in all
cases (Figure 3e).
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Figure 2 Sensor characterization in a controlled pressure chamber. (a) Intraocular pressure (IOP) sensor characterization in a controlled
pressure chamber with a digital pressure gauge. A schematic of the sensor optical resonance detector is shown above the pressure chamber.
(b) Experimentally determined spectra from the sensor in the pressure range from 1 to 40 mm Hg with the spectra corresponding to 1 mm Hg
shown at the top and the spectra for 40 mm Hg shown at the bottom. The spectra for the intervening IOPs are shown in sequence from top to
bottom. (c) Theoretically predicted spectra corresponding to the pressure range from 1 (top spectra) to 40 mm Hg (bottom spectra). (d) Highly
linear, very close one-to-one matching between the sensor measurements (vertical axis) and the digital pressure-gauge readouts (horizontal
axis). The black line shows a theoretical perfect match of sensor and digital pressure-gauge readings, and the red circles indicate actual
experimental measurements corresponding to the pressure readout based on the optomechanical model (OMM). Histogram shows the error
distribution (RMSE: 0.29 mm Hg). Even in the worst case, the sensor reading was within ± 1 mm Hg of the digital pressure-gauge readings.
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Sensor performance in rabbit eyes in vivo
Sensors whose performance metrics had been fully characterized
in the controlled pressure chamber were implanted into the eyes
of New Zealand white rabbits to investigate their performance
in vivo. Two methods were used for sensor implantation. In one
method, individual sensors were attached to an intraocular lens
(IOL) (Figure 4a) and placed into the lens capsular bag following
the surgical extraction (See section “Surgical Procedures” in
Supplementary Information) of the crystalline lens (Figures 4b
and c; Supplementary Video 1). A cavity of approximately 1 mm in
diameter and 0.5 mm in depth was mechanically cut into the IOL.
Sensors were placed into this cavity using medical grade UV
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Figure 3 Sensors in ex vivo rabbit eyes and spectra collected over a range of induced intraocular pressures (IOPs). (a) A photograph of an
implanted sensor inside the anterior chamber of an ex vivo rabbit eye. (b) A microscope image showing the 200-μm2 nanodot array of a sensor
taken thorough the cornea and the aqueous humor in an ex vivo eye. (c) The spectra from a sensor tested in the controlled pressure chamber
for pressures. The open symbols show the location of the three reﬂected resonance peaks. (d) The spectra from the same sensor shown in c
when tested in an ex vivo eye as the internal pressure of the ex vivo eye was varied using a 21-gauge needle and a syringe pump. Red symbols
show the location of the three reﬂected resonance peaks. (e) Mapping comparison between the sensor’s pressure readout obtained from
pressure chamber testing (black circle) and ex vivo eye testing (red circle). The vertical axis indicates sensor measurements and the horizontal
axis indicates the digital pressure-gauge readouts. The black error bars indicate standard deviations (n= 15).
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Figure 4 Nanodot-enhanced IOP sensors in rabbit eyes. (a) An IOP sensor attached to a one-piece acrylic IOL. The sensor is the black circular
object with a central bright area that represents the nanodot array. (b) A nanodot-enhanced IOP sensor (located within the dashed circle)
implanted into a rabbit eye. (c) A higher magniﬁcation view of the same sensor as in b. The bright square in the middle of the sensor
represents the nanodot array. The translucent material surrounding the sensor is the epoxy adhesive used in the sensor assembly and sensor
attachment to the IOL. (d) A nanodot-enhanced sensor attached to thin silicone membrane haptics. (e) A nanodot-enhanced sensor mounted
on silicone haptics (located within the dashed circle) implanted into a rabbit eye. (f) Higher magniﬁcation of the same sensor as in e. The
bright square in the middle of the sensor represents the nanodot array. The silicone haptics appear transparent after implantation into
the eye.
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adhesive (Loctite 3321, Loctite Corp. Rocky Hill, CT, USA) with the
deformable membrane side facing outwards from the IOL cavity.
In the other method, sensors were attached to 125-μm-thick clear
silicone-membrane haptics (Figure 4d), and rolled up for insertion
into the anterior chamber through a clear corneal incision. The
silicone haptics were manually fabricated from medical grade
silicone membrane (125 μm thick) (BioPlexus, Ventura, CA, USA)
into a barbell shape approximately 2.5 mm in width and 12.5 mm
in length. The two haptic arms then spontaneously unfolded to
extend into the iridocorneal angle and mechanically anchor the
sensor within the anterior chamber (Figures 4e and f;
Supplementary Video 2).
Next, we characterized the in vivo performance of implanted
sensors in rabbit eyes using the remote optical detector. The data
reported here were obtained from ﬁve sensors implanted in ﬁve
rabbits (or one sensor per rabbit) for up to 4.5 months. The optical
alignment was carried out by monitoring both camera image and
the spectra in real time. The initial alignment between the sensor
and the detector was achieved relatively easily by using a co-
axially integrated USB-camera and maximizing the reﬂection back
from the sensor until the sensor appeared as a bright spot
saturated with light in the image. We know from the bench-top
testing that the bright spot guarantees an optical alignment
within ± 3° (Supplementary Figure S8). Then the alignment was
further improved by manipulating the mini-translational stages of
the detector until the resonance amplitude captured by the
spectrometer appeared maximized. This would lead to an
alignment accuracy within ± 1°. Furthermore, in order to reduce
the potential error in angular alignment during in vivo measure-
ments, we continuously record the spectra at a sampling rate of
10 Hz and choose only the highest-quality spectra with SNR over
15 dB. Using this high-speed sampling approach allowed us to
ﬁlter out erroneous measurements with low SNRs in post-
measurement processing and to minimize the IOP-estimation
error that could results from movements (such as breathing) of the
test subject. During each recording session, the resonance spectra
from the sensor were recorded at a rate of 10 Hz for 20 s.
Examples of 20 individual resonance spectra collected over 2 s
from a sensor following the in vivo implantation are shown in
Figure 5a. The captured resonance signals were stable, with an
excellent signal-to-noise ratio (SNR) of 15 dB, which was close to
16 dB measurement that had been observed during pressure-
chamber characterization. The deterioration in SNR above
1050 nm originated from the decreased sensitivity of the silicon
detector used in the spectrometer. IOP measurements were also
performed concurrently using a commercial rebound tonometer
(TonoVet, Icare, Vanda, Finland).
The ability of nanodot-enhanced sensors to report the short-
term increases and decreases in IOP in vivo was tested on
anesthetized rabbits. We injected 5% hypertonic saline intravi-
treally into the eyes with the implanted sensors to cause a quick
transient increase in IOP to a peak of 25–30 mm Hg followed by a
gradual return to the baseline over approximately 1.5–2 h. The
resonance spectra of the sensors were captured in parallel with
IOP measurements using the TonoVet for 45–60 min after these
injections. An example of the experimentally induced IOP proﬁle
measured by the nanodot-enhanced sensor and by the TonoVet is
shown in Figure 5b. Prior to the saline injection, the sensor-
recorded IOP was 8 mm Hg and the TonoVet-derived IOP was
6.3 mm Hg. The ﬁrst sensor-recorded IOP captured at approxi-
mately 2 min after the intravitreal saline injection showed an
increase in IOP to 27.0 mm Hg (see also Supplementary Figure S6),
which was followed by a gradual decrease over 43 min. This
mirrored the IOP changes recorded by the TonoVet (Figure 5b).
Moreover, the IOPs from nanodot-enhanced sensors have been
measured for up to 138 days after the in vivo implantation.
(138 days represents the last data point obtained prior to the
submission of this manuscript). Figure 5c shows six IOP measure-
ments obtained from an implanted sensor and six concurrent IOP
measurements obtained using the TonoVet on Days 0, 20, 40, 76,
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110, and 138 after implantation. IOP readings from the sensor on
each day were averaged from 200 measurements made over 20 s:
these were 7.8 ± 0.16 (Day 0), 5.3 ± 0.24 (Day 20), 7.7 ± 0.27 (Day
40), 12.3 ± 0.19 (Day 76), 3.9 ± 0.45 (Day 110), and 6.6 ± 0.54 (Day
138) mm Hg. The corresponding TonoVet IOP readings were
6.7 ± 0.6 (Day 0), 6.0 ± 1.0 (Day 20), 8.7 ± 0.6 (Day 40), 11.3 ± 0.6
(Day 76), 5.7 ± 0.6 (Day 110) and 6.3 ± 0.6 (Day 138) mm Hg. Each
TonoVet IOP value is an average of 3–6 individual measurements.
DISCUSSION
The present study has provided proof of concept for the remote
detection of IOP from an implanted nanodot-enhanced IOP sensor
using invisible NIR light. The sensor is extremely compact and
measures less than 1 mm in size. The bench testing in a controlled
pressure chamber demonstrated IOP readings in the clinically
useful range of 0–40 mm Hg with an average accuracy of
0.29 mm Hg and in the ex vivo eyes with an accuracy of
± 1.3 mm Hg when measured against a commercial pressure
gauge in both cases. In our algorithm, the locations of the
extrema (that is, peaks or valleys) determine the pressure.
Therefore, when one of the extrema completely shifts out of the
measurement-spectrum window, the magnitude of the inaccuracy
suddenly increases. If we avoid a shift-out by limiting the
measurement range to, for example, between 10 and 11 mm Hg,
the sensor provided a much-improved pressure resolution of
0.07 mm Hg (Supplementary Figure S7). Such a ﬁne level of
pressure resolution easily exceeds the 1-mm Hg resolution
observed in commercial tonometers and is very promising. In
vivo testing showed that implanted sensors were able to reliably
measure short-term increases and decreases in IOP that matched
concurrently obtained TonoVet IOP readings. Furthermore, the
sensor performance was also conﬁrmed over a period of 138 days
during which the sensor’s IOP readings paralleled those obtained
using the TonoVet. The remote optical detector also has a simple
conﬁguration that allows easy optical alignment for use in a
laboratory and clinics, and it can be further simpliﬁed and
implemented in a form of a hand-held detector for use in the
home environment.
The results from sensor testing in ex vivo eyes showed that IOP
readings of the sensor differed from IOPs determined by the
commercial pressure gauge by ± 1.3 mm Hg (Figure 3d). This
accuracy improves to ± 0.29 mm Hg over the 0–40 mm Hg range
when the same sensor was characterized in the controlled
pressure chamber using the commercial pressure gauge
(Figure 2d). In ex vivo eye testing, the pressure gauge was
connected to the inﬂow line, and the inﬂow line tip was inserted
through an entry point into the eye. As a result, the pressures
sensed by the pressure gauge and the sensor in the eye may be
slightly different due to several factors including the difﬁculty in
establishing a tight seal around the infusion tubing at its insertion
point into the ex vivo eye for an extended period of time, and the
challenge of maintaining a stable pressure level given the intact
outﬂow pathways in an ex vivo eye.
In vivo IOP readings from the sensors were all compared to
those obtained using the TonoVet rebound tonometer to avoid
repeated use of invasive manometric determinations of IOP. As
the TonoVet is a hand-held tonometer, its readings are affected by
inherent variations in positioning and by the corneal surface
hydration state of the anesthetized rabbits during the recording
session. Nevertheless, all but one sensor reading were within the
2-mm Hg error range of the concurrently performed TonoVet
readings. (The manufacturer-speciﬁed accuracy of the TonoVet
utilized in our studies was ± 2 mm Hg.) Note that the TonoVet is
not speciﬁcally calibrated by the manufacturer for rabbit corneal
biomechanical properties, and its IOP readings from rabbits are
known to be systematically lower than intraocularly determined
manometric IOPs86. More precise and detailed characterization of
our sensor’s in vivo performance in subsequent work will require
improved reference-IOP measurements in the eye.
Our system’s temporal resolution is 10 Hz, and capturing a
single spectrum necessary for an IOP measurement requires only
0.1 s. This implies that the system can easily detect changes in IOP
in less than 1 s. The 2-second blocks of continuous IOP data
(measured at 10 Hz) in Figure 5a showed that the nanodot-
enhanced IOP system exhibited good consistency and stability,
which was observed over the entire 20 s recording period.
Two different types of sensor-delivery platforms were utilized in
this study. The sensor attachment to an IOL takes advantage of
well-developed existing cataract surgery and IOL delivery
methods, while sensors mounted onto thin silicone haptics for
ﬁxation have the advantage of requiring a smaller corneal incision
and no further surgical interventions. As a result, sensors could be
inserted in 5 min instead of requiring 15 min for invasive lens
extraction and IOL insertion. The silicone-haptic approach
provided an additional beneﬁt of decreasing the distance
between the corneal surface and the sensor from 3–4 mm to 1–
2 mm, and this reduction in distance decreased the attenuation
through the aqueous humor and the light dispersion caused by
the curvature of the cornea. As a result, the SNR of the optical
readout increased from 12 to 15 dB, which was comparable to the
SNR of 16 dB observed during the bench testing. Lastly, if
nanodot-enhanced IOP sensors are eventually used in the clinical
setting, sensors mounted on silicone haptics can potentially be
implanted in all glaucoma patients in addition to those under-
going lens extraction and IOL placement.
Sensors attached onto the IOLs were implanted using standard
surgical techniques for lens phacoemulsiﬁcation and IOL implan-
tation. This surgical procedure by itself, independent of an
attached sensor, can cause corneal edema and a substantial
inﬂammatory tissue reaction in the rabbit eyes, particularly during
the ﬁrst 1–2 weeks after surgery. As the ocular conditions during
the ﬁrst two post-operative weeks after IOL implantation were
suboptimal for capturing sensor optical resonance signals, we
primarily utilized the sensors attached onto IOLs for longer-term
studies beyond 1 month after implantation. On the other hand,
sensors mounted on silicone haptics did not elicit any noticeable
inﬂammatory reaction in the anterior chamber after implantation,
and the ocular recovery was excellent even on the second day
after surgery with only mild incisional edema. Tissue buildup
following a 4-month implantation period was noted to be minimal
with no evidence of toxicity. As of the manuscript submission
date, all of the sensors (n= 5) remained functional and operational.
We will continue to investigate their in vivo performance until we
have a device failure. Our previous work revealed that the use of
nanoscale textured surfaces such as black-silicon on implants can
greatly improve the anti-biofouling properties, suggesting an
effective way to improve biocompatibility of the sensors87. A more
detailed histological examination of the sensors will be performed
at the end of the study when they are retrieved from the rabbits
for re-characterization in the pressure test chamber.
The current version of the nanodot-enhanced IOP sensor is
almost an order of magnitude smaller than sensors based on the
LC coupling, and further miniaturization is possible. The vertical
and lateral dimensions of the sensors can be reduced to 50 and
200 μm, respectively, by using a thinner silicon-on-insulator wafer
for fabrication and employing smaller diaphragm designs without
degrading the sensor’s mechanical properties. Currently, the
sensor size is dictated by the minimum bonding area required
to achieve a reliable water-proof seal between the top and bottom
structures, and this can be overcome by improving the fabrication
or packaging technologies.
In summary, the IOP-monitoring system provides a battery-free
operation, invisible interrogation, and convenient and rapid IOP
measurements. The implantable IOP sensor is three orders of
magnitude smaller than commercially available devices48,65,
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minimizing the risks associated with implantation procedures as
well as post surgery and long-term complications. We proﬁled
dynamic changes of IOP in anesthetized rabbits for short-term
(1 h) and in awake rabbits for long-term (4.5 months) periods, with
an average accuracy of 0.29 mm Hg at a rate of 10 Hz over the
physiologically interested range of 0–40 mm Hg. With further
sensor reﬁnements and detector automation, the system can
become a viable choice for patient-initiated IOP monitoring in the
home environment and drug-discovery research in labs. Its use
will improve glaucoma management and expedite the search for
better glaucoma treatment.
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